Our Experts

Physician Profile

412-692-5170 Phone
412-692-5834 Fax

Ingrid Libman DeGordon, MD, PhD

Ingrid Libman, MD
Job Title Associate Professor, Division of Pediatric Endocrinology, Department of Pediatrics, Children's Hospital of Pittsburgh of UPMC
4401 Penn Avenue, Suite Floor 3
Pittsburgh, PA 15224
412-692-5170 Phone
412-692-5834 Fax

Education and Training

Medical School:

1991 MD, Rosario Medical School, Rosario, Argentina
1996 PhD, University of Pittsburgh, Pittsburgh, PA


2001 Pediatrics, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA


1996 Post-Doctoral Fellow, University of Pittsburgh, Pittsburgh, PA
1998 Pediatric Endocrinology Research Fellow, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
2004 Pediatric Endocrinology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA


  • American Diabetes Association     
  • Latin American Diabetes Association     
  • European Association for the Study of Diabetes   
  • International Society for Pediatric and Adolescent Diabetes

Board Certifications

  • Pediatrics
  • Pediatric Endocrinology


  • Individual National Research Service Award, National Institutes of Health (NIH), Post-doctoral Fellowship
  • Delta Omega Honor Society, Honor Society for Public Health
  • 1997, 2000, 2004 Travel Grant Award, American Diabetes Association Annual Meeting
  • 1998, 1999, 2000, 2001 Travel Grant Award, European Association for the Study of Diabetes Annual Meeting
  • Pediatric Endocrinology Preceptorship Program 2004, Endocrine Fellows Foundation, Children’s Hospital Los Angeles, California
  • Co-Chair, Surveillance Group, PA Diabetes Stakeholder Initiative, PA Department of Health
  • Honorary Member, Dominican Republic Society of Endocrinology 
  • Outstanding Achievement in Patient Care – Patient Satisfaction Award, Children’s Hospital of Pittsburgh of UPMC


  • Libman I, Sun K, Foley T, Becker D. Thyroid Autoimmunity in Children with Features of Both Type 1 and Type 2 Diabetes. Pediatric Diabetes (In press).
  • Witchel S, White C, Libman I. Association of the -243 A/G Polymorphism of the Glutamate Decarboxylase 2 (GAD2) Gene with Obesity in Girls with Premature Pubarche. Fertility and Sterility (In press).
  • Libman I, Barinas-Mitchell E, Bartucci A, Robertson R, Arslanian S. Reproducibility of the Oral Glucose Tolerance Test in Overweight Children. JCEM (Submitted).

    View Dr. Libman's full list of publications from PubMed.

Research Interests

  • Type 1 and type 2 diabetes epidemiology in childhood, racial differences
  • Concept of “double” diabetes in childhood
  • Impact of obesity in type 1 diabetes
  • Screening methods for type 2 diabetes in obese children and adolescents

Biography Summary

Ingrid Libman, MD, PhD, is an Associate Professor in the Division of Pediatric Endocrinology and Diabetes at Children’s Hospital of Pittsburgh of UPMC. She also holds a secondary appointment in the Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh. Her scientific interests focus on the etiology, prevention and treatment of diabetes in childhood, with particular emphasis on the effect of obesity and insulin resistance in type 1 diabetes mellitus (T1DM). Dr. Libman obtained her MD at the Universidad Nacional de Rosario, Argentina and then pursued a Masters followed by a PhD in Public Health at the University of Pittsburgh, Pittsburgh, Pennsylvania. Upon graduation, her clinical interest and desire to become a clinical researcher led her to complete a residency program in pediatrics followed by a fellowship in pediatric endocrinology, both at Children’s Hospital of Pittsburgh. She then joined as faculty.

As part of her PhD thesis, she described a dramatic rise in the incidence of T1DM in the adolescent population, particularly in African Americans. This was followed by the finding that some children have characteristics of both type 1 and type 2 diabetes disease processes, in particular African Americans, who had evidence of β cell autoimmunity but also clear characteristics of insulin resistance, including overweight and acanthosis nigricans. A significant career contribution to the literature was the first recognition that obesity was present in children with T1DM with rising frequency over decades. She is currently exploring the effect of overweight and insulin resistance on early CVD risk factors and markers in children with T1DM. Her continued interest in this field has led to her current role as study co-chair of a multicenter US clinical trial to assess the efficacy and safety of metformin in overweight children with T1DM.

In her free time, Dr. Libman enjoys spending time with her family and travelling.

Active Research Projects / Grants

  • Are overweight children with T1DM at increased risk
    of cardiovascular disease?
Last Update
January 26, 2015
  • Increase/Decrease Text Size
  • Print This Page
Last Update
January 26, 2015